The global market for non-steroidal anti-inflammatory drugs (NSAIDs) is expected to experience substantial growth driven by rising chronic pain and inflammatory conditions. The aging population and the preference for NSAIDs due to their lower side effects compared to other pain relievers are key contributors to this trend. The market is further boosted by increased drug approvals, new product launches, and ongoing research and development efforts.